Prelude Therapeutics
Biotechnology Research · 51 Employees
Phone Number: 3024671280
Email Address: info@preludetx.com
- Overview
- Employees
Access 117 Verified Employees Profiles for Prelude TherapeuticsUnlock Free Contacts Now
About
Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company’s diverse pipeline is comprised of highly differentiated, potentially best-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways for cancers with selectable underserved patients. Prelude’s pipeline includes three candidates currently in clinical development: PRT3789 an IV administered, potent and highly selective SMARCA2 degrader, PRT2527, a potent and highly selective CDK9 inhibitor, PRT3645 a next generation CDK4/6 inhibitor, and a preclinical oral candidate targeting SMARCA2.
Website
Year Founded
2016
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
175 Innovation Boulevard
Wilmington, DE 19805, US
Keywords
OncologyCancer therapeuticsPrecision medicinesBiotechPrecision oncologyCancer Researchsmall molecule therapiescancer biologyand cancer biology
Location
- 175 Innovation Boulevard Wilmington, DE 19805, US
Email Formats
Sign up for free credits and discover verified email addresses of Prelude Therapeutics
FormatExamples
first + last
andywarhol@preludetx.com
first_initial + last
awarhol@preludetx.com
first + last_initial
andyw@preludetx.com
first
andy@preludetx.com
last
warhol@preludetx.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Prelude Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.